[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523704":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":39,"responsibleParty":58,"collaborators":62,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":18,"enrollmentInfo":75,"targetDuration":18,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Herlev and Gentofte Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"HeartLogic-guided management","EXPERIMENTAL","HeartLogic alerts will be transmitted to the study team, which will subsequently contact the participant to assess any treatment needs. Treatment needs will be assessed according to current clinical practice guidelines.",[13],"Other: HeartLogic",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard care","NO_INTERVENTION","The control group will receive usual HF care in the Danish health system.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"HeartLogic","HeartLogic alerts will be managed according to a standardized alert management guide to ensure uniform reactions to HeartLogic alerts.",[9],[25],{"name":26,"affiliation":27,"role":28},"Tor Biering-Sørensen, MD, MSc, MPH, PhD","Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte","STUDY_CHAIR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Niklas Dyrby Johansen, MD","CONTACT","+4520204794","niklas.dyrby.johansen@regionh.dk",{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},"Marie Terese Barlebo Madsen, PhD","+4553377345","marie.terese.barlebo.madsen@regionh.dk",[40],{"facility":27,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Hellerup","Capital Region","2900","Denmark","DK",{"type":48,"coordinates":49},"Point",[50,51],12.57093,55.73204,{"lat":51,"lon":50},[54,55,56],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},{"name":26,"role":57,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Tor Biering-Sørensen","Professor, MD, MSc, MPH, PhD, MP",[63],{"name":64,"class":65},"Boston Scientific Corporation","INDUSTRY","100523704","danish-pragmatic-randomized-trial-to-evaluate-the-effect-of-heartlogic-guided-management-on-heart-failure-outcomes-100523704",false,"NCT06099158","Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes","DANLOGIC-HF","Inclusion Criteria:\n\n1. Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization\n2. Age ≥18 years\n3. Compliant with remote monitoring and not listed in the LATITUDE™ remote monitoring system as \"not monitored\"\n\nExclusion Criteria:\n\nThere are no specific exclusion criteria for the trial.","ALL","18 Years",{"count":76,"type":77},1428,"ESTIMATED","INTERVENTIONAL",[80],"NA","The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.",[83],"Heart Failure",[85,86,87,88,89,90,21],"Pragmatic","Heart disease","ICD","CRT-D","Pacemaker","Registry","2025-09-08",{"date":93,"type":94},"2025-09-12","ACTUAL",{"date":96,"type":94},"2024-05-31",{"date":98,"type":77},"2027-12-01",{"name":60,"class":6},1]